Mutations in the COL1A2 gene of type I collagen that result in nonlethal forms of osteogenesis imperfecta
- 15 January 1993
- journal article
- Published by Wiley in American Journal of Medical Genetics
- Vol. 45 (2) , 228-232
- https://doi.org/10.1002/ajmg.1320450215
Abstract
Although virtually all mutations that result in osteogenesis imperfecta (OI) affect the genes that encode the chains of type I procollagen, the effects of mutations in the COL1A2 gene have received less attention than those in the COL1A1 gene. We have characterized mutations in 4 families that give rise to different OI phenotypes. In three families substitutions of glycine residues by cysteine in the triple helical domain (a single example at position 259 and 2 families in which substitution of glycine at 646 by cysteine) have been identified, and in the fourth a G for A transition at position + 4 in intron 33 led to use of an alternative splice site and inclusion of 6 amino acids (val‐gly‐arg‐ile‐leu‐phe) between residues 585 and 586 of the normal triple helix. The relation between position of substitution of glycine by cysteine in the COL1A2 gene does not follow the pattern developed in the COL1A1 gene. To determine how COL1A2 mutations produce OI phenotypes, we have produced a full‐length mouse cDNA into which we plan to place mutations and examine their effects in stably transfected osteogenic cells and in transgenic animals.Keywords
This publication has 12 references indexed in Scilit:
- Construction of a Full-Length Murine Proα2(I) Collagen cDNA by the Polymerase Chain ReactionJournal of Investigative Dermatology, 1991
- A substitution at a non-glycine position in the triple-helical domain of pro alpha 2(I) collagen chains present in an individual with a variant of the Marfan syndrome.Journal of Clinical Investigation, 1990
- Osteogenesis Imperfecta Type IVAnnals of the New York Academy of Sciences, 1990
- Frameshift mutation near the 3' end of the COL1A1 gene of type I collagen predicts an elongated Pro alpha 1(I) chain and results in osteogenesis imperfecta type I.Journal of Clinical Investigation, 1990
- Osteogenesis imperfecta. The position of substitution for glycine by cysteine in the triple helical domain of the pro alpha 1(I) chains of type I collagen determines the clinical phenotype.Journal of Clinical Investigation, 1989
- Clinical variability of osteogenesis imperfecta linked to COL1A2 and associated with a structural defect in the type I collagen molecule.Journal of Medical Genetics, 1989
- A human beta-actin expression vector system directs high-level accumulation of antisense transcripts.Proceedings of the National Academy of Sciences, 1987
- Diminished type I collagen synthesis and reduced alpha 1(I) collagen messenger RNA in cultured fibroblasts from patients with dominantly inherited (type I) osteogenesis imperfecta.Journal of Clinical Investigation, 1985
- In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria.The Journal of cell biology, 1983
- Proteolytic enzymes as probes for the triple-helical conformation of procollagenAnalytical Biochemistry, 1981